Werewolf Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $-49 | $49 |
Gross Profit | -406 | -426 | -967 | -454 |
EBITDA | -16,275 | -16,400 | -18,691 | -14,975 |
EBIT | -16,681 | -16,826 | -19,133 | -15,429 |
Net Income | -17,982 | -18,089 | -20,400 | -16,673 |
Net Change In Cash | 0 | 0 | -49 | 49 |
Free Cash Flow | -15,164 | -18,948 | -14,375 | -12,465 |
Cash | 78,491 | 92,042 | 110,995 | 122,827 |
Basic Shares | 44,981 | 44,827 | 44,480 | 43,704 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $1,885 | $19,943 | $16,401 | $4,148 |
Gross Profit | 71 | 18,179 | 16,401 | -735 |
EBITDA | -64,045 | -32,465 | -54,952 | -49,871 |
EBIT | -65,859 | -34,229 | -56,056 | -50,087 |
Net Income | -70,515 | -37,368 | -51,564 | -49,767 |
Net Change In Cash | 1,885 | 19,943 | 16,401 | 4,148 |
Cost of Revenue | -28,301 | 66,053 | ||
Free Cash Flow | -56,442 | -33,381 | -44,207 | -43,374 |
Cash | 110,995 | 134,343 | 129,315 | 157,531 |
Basic Shares | 43,859 | 35,646 | 28,864 | 27,313 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.40 |
2025-03-31 | -$0.40 |
2024-12-31 | -$0.46 |
